Search Results

Collaborations between product development partnerships and the World Health Organization.

• Authors : Helble M; Research for Health department, Science Division, World Health Organization, Avenue Appia 20, 1211 Geneva 27, Switzerland.; Kuchenmüller T

Subjects: International Cooperation* ; Drug Development* ; Vaccine Development*

• Source: Bulletin of the World Health Organization [Bull World Health Organ] 2023 May 01; Vol. 101 (5), pp. 355-357. Date of Electronic Publication: 2023 Mar Publisher: World Health Organization Country of Publication: Switzerland NLM ID: 7507052 Publication Model: Print-Electronic

Record details

An mRNA technology transfer programme and economic sustainability in health care.

• Authors : Dutt, Devika; Mazzucato, Mariana; Torreele, Els

Subjects: VACCINE development; MIDDLE-income countries; WORLD Health Organization

• Source: Bulletin of the World Health Organization. May2024, Vol. 102 Issue 5, p344-351. 8p.

Record details

Genetic and antigenic characteristics of zoonotic influenza A viruses and development of candidate vaccine viruses for pandemic preparedness.

Subjects: INFLUENZA prevention; INFLUENZA epidemiology; VACCINE development

• Source: Weekly Epidemiological Record. 3/29/2024, Vol. 99 Issue 13, p147-162. 15p.

Record details

COVID-19 vaccine development, production and regulatory oversight in African countries.

• Authors : Makenga G; National Institute for Medical Research, Tanga Centre, PO Box 5004, Hospital street, Tanga 255, Tanzania.; Booy R

Subjects: COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19 Vaccines*

• Source: Bulletin of the World Health Organization [Bull World Health Organ] 2022 Oct 01; Vol. 100 (10), pp. 651-652. Date of Electronic Publication: 2022 SepPublisher: World Health Organization Country of Publication: Switzerland NLM ID: 7507052 Publication Model: Print-Electronic

Record details

Recommended composition of influenza virus vaccines for use in the 2024 southern hemisphere influenza season.

Subjects: INFLUENZA vaccines; WORLD Health Organization; INFLUENZA A virus

• Source: Weekly Epidemiological Record. 10/27/2023, Vol. 98 Issue 43, p521-533. 13p.

Record details

Genetic and antigenic characteristics of zoonotic influenza A viruses and development of candidate vaccine viruses for pandemic preparedness.

Subjects: INFLUENZA vaccines; INFLUENZA A virus; VIRAL vaccines

• Source: Weekly Epidemiological Record. 10/27/2023, Vol. 98 Issue 43, p533-553. 21p.

Record details

Reassessing potential economic value and health impact of effective Shigella vaccines.

• Authors : Hausdorff, William P.; Anderson IV, John D.; Bourgeois, A. Louis

Subjects: ANTIBIOTICS; DIARRHEA prevention; WORLD Health Organization

• Source: Bulletin of the World Health Organization. Jan2024, Vol. 102 Issue 1, p65-74. 10p.

Record details

Genetic and antigenic characteristics of zoonotic influenza A viruses and development of candidate vaccine viruses for pandemic preparedness.

Subjects: INFLUENZA vaccines; GENETICS; INFLUENZA A virus

• Source: Weekly Epidemiological Record. 3/24/2023, Vol. 98 Issue 12, p111-125. 15p.

Record details

Recommended composition of influenza virus vaccines for use in the 2023--2024 northern hemisphere influenza season.

Subjects: INFLUENZA vaccines; WORLD Health Organization; INFLUENZA A virus

• Source: Weekly Epidemiological Record. 3/17/2023, Vol. 98 Issue 11, p99-110. 12p.

Record details

Antigenic and genetic characteristics of zoonotic influenza A viruses and development of candidate vaccine viruses for pandemic preparedness.

Subjects: INFLUENZA vaccines; GENETICS; INFLUENZA A virus

• Source: Weekly Epidemiological Record. 10/28/2022, Vol. 97 Issue 43, p550-565. 16p.

Record details